MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    First approach of a sensor-based assessment of the camptocormia angle

    K. Knutzen, K. Naderi Beni, R. Wolke, J. Kuhtz-Buschbeck, R. Rieger, NG. Margraf (Kiel, Germany)

    Objective: To implement inertial-measurement-unit (IMU) sensors as a reliable and valid diagnostic tool in assessing the camptocormia angle (CA). Background: Camptocormia is a pathological non-fixed…
  • 2023 International Congress

    Preoperative trajectory planning is important to minimize intracerebral hemorrhage after deep brain stimulation, in comparison with ventricle peritoneal shunt.

    T. Nakura, S. Taguchi, H. Saiki, S. Miyachi, M. Douyuu (Nagakute, Japan)

    Objective: We compared the occurrence of postoperative intracerebral hemorrhage (ICH) in deep brain stimulation (DBS) and ventricle peritoneal (VP) shunt at our institution. Background: Although…
  • 2023 International Congress

    Analysis of α-Synuclein Seed Amplification Assay in Carriers of GBA and LRRK2 Pathogenic Variants

    K. Fraser, A. Mirelman, O. Mabrouk, N. Omer, L. Concha-Marambio, T. Gurevich, A. Bar Shira, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, M. Kestenbaum, J. Cedarbaum, T. Dam, J. Shirvan, N. Giladi, D. Graham, R. Alcalay, A. Thaler (Cambridge, USA)

    Objective: To assess α-synuclein seed amplification assay (αS-SAA) in cerebrospinal fluid (CSF) from a cohort of PD patients and non-manifesting carriers (NMCs) of pathogenic GBA…
  • 2023 International Congress

    Initial 24-hours Levodopa Carbidopa Intestinal Gel initiation in advanced Parkinson’s disease

    J. Szász, V. Constantin, K. Orban-Kiss, S. Bataga, L. Bancu, R. Neagoe, J. Szederjesi, M. Ciorba, I. Mihaly, K. Kelemen, S. Szatmari (TARGU MURES, Romania)

    Objective: To evaluate the profile of those patients with advanced Parkinson’s Disease (APD) in which we decided to use continuous 24-hour administration of Levodopa Carbidopa…
  • 2023 International Congress

    Ocular microtremor in Parkinson’s Disease: Protocol for an observational pilot study

    L. Graham, R. Morris, R. Vitorio, S. Stuart, A. Godfrey, R. Walker, C. Mcdonald (Newcastle, United Kingdom)

    Objective: This study aims to examine OMT in people with PD (PwPD) compared to healthy older adults. Identifying OMT as a PD biomarker could better…
  • 2023 International Congress

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

    H. Berven, S. Kverneng, E. Sheard, M. Søgnen, S. Geijerstam, K. Haugarvoll, GO. Skeie, C. Dölle, C. Tzoulis (Bergen, Norway)

    Objective: To determine the safety of oral nicotinamide riboside (NR) 3000 mg daily for 4 weeks in Parkinson’s disease (PD). Secondary objectives: To assess NRs…
  • 2023 International Congress

    The spatial and spectral organization of thalamo-cortical connectivity in patients with essential tremor

    A. Steina, S. Schnitzler, J. Vesper, E. Florin, A. Schnitzler, J. Hirschmann (Düsseldorf, Germany)

    Objective: To identify cortical areas coupled to the ventral intermediate nucleus of the thalamus (VIM) in patients with essential tremor (ET). Background: ET is a…
  • 2023 International Congress

    Risk factors for Freezing of Gait in Parkinson’s Disease: A Systematic Review and Meta-analysis

    X. Zheng, J. Liu, S. Wang, R. Ou, C. Li, H. Shang (Chengdu, China)

    Objective: To comprehensively identify risk factors of freezing of gait (FOG) in Parkinson’s disease (PD), we performed a meta-analysis by combining the results of previous…
  • 2023 International Congress

    The association between compliance and the effects of home-based touchscreen training in Parkinson’s disease

    J. de Vleeschhauwer, E. Nackaerts, Y. Zhang, L. Janssens, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: To explore whether training success is determined by compliance as well as by cognitive function, depression and levodopa equivalent dosage (LEDD). Background: Training compliance…
  • 2023 International Congress

    Continuity and presence of side effects of continuous subcutaneous apomorphine infusion and levodopa-carbidopa intestinal gel infusion in advanced Parkinson’s disease, in a movement disorder unit in Spain

    I. Muro Garcia, J. Alonso Maroto, B. Gonzalez Garcia, E. Carabajal Pendon, E. Casas, L. Lopez Manzanares (Madrid, Spain)

    Objective: To determine the number of patients that maintain infusion therapies (continuous subcutaneous apomorphine infusion (CSAI) and levodopa-carbidopa intestinal gel (LCIG)) as treatment for advanced…
  • « Previous Page
  • 1
  • …
  • 261
  • 262
  • 263
  • 264
  • 265
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley